{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:13:55Z","timestamp":1789413235281,"version":"build-2803163510"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IRCCS Foundation Policlinico San Matteo"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In the ESC 2023 guidelines, cardiomyopathies are conservatively defined as \u2018myocardial disorders in which the heart muscle is structurally and functionally abnormal, in the absence of coronary artery disease, hypertension, valvular disease, and congenital heart disease sufficient to cause the observed myocardial abnormality\u2019. They are morpho-functionally classified as hypertrophic, dilated, restrictive, and arrhythmogenic right ventricular cardiomyopathy with the addition of the left ventricular non-dilated cardiomyopathy that describes intermediate phenotypes not fulfilling standard disease definitions despite the presence of myocardial disease on cardiac imaging or tissue analysis. The new ESC guidelines provide \u2018a guide to the diagnostic approach to cardiomyopathies, highlight general evaluation and management issues, and signpost the reader to the relevant evidence base for the recommendations\u2019. The recommendations and suggestions included in the document provide the tools to build up pathways tailored to specific cardiomyopathy (phenotype and cause) and define therapeutic indications, including target therapies where possible. The impact is on clinical cardiology, where disease-specific care paths can be assisted by the guidelines, and on genetics, both clinics and testing, where deep phenotyping and participated multi-disciplinary evaluation provide a unique tool for validating the pathogenicity of variants. The role of endomyocardial biopsy remains underexploited and confined to particular forms of restrictive cardiomyopathy, myocarditis, and amyloidosis. New research and development will be needed to cover the gaps between science and clinics. Finally, the opening up to disciplines such as bioinformatics, bioengineering, mathematics, and physics will support clinical cardiologists in the best governance of the novel artificial intelligence\u2013assisted resources.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suae002","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:29:25Z","timestamp":1713353365000},"page":"i1-i5","source":"Crossref","is-referenced-by-count":15,"title":["The new 2023 ESC guidelines for the management of cardiomyopathies: a guiding path for cardiologist decisions"],"prefix":"10.1093","volume":"26","author":[{"given":"Maurizia","family":"Grasso","sequence":"first","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Bondavalli","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Vilardo","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cavaliere","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Gatti","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Di Toro","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Giuliani","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Urtis","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"},{"name":"Department of Electrical, Computer and Biomedical Engineering, University of Pavia , Pavia 27100 , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Cattadori","sequence":"additional","affiliation":[{"name":"Cardiac Surgery, Department of Intensive Medicine, Fondazione IRCCS Policlinico San Matteo , 27100 Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Serio","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Pellegrini","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"},{"name":"Cardiac Surgery, Department of Intensive Medicine, Fondazione IRCCS Policlinico San Matteo , 27100 Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Arbustini","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"2024041706385159500_suae002-B1","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":". 2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2024041706385159500_suae002-B2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"2024041706385159500_suae002-B3","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/eurheartj\/ehq271","article-title":". Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology working group on myocardial and pericardial diseases","volume":"31","author":"Charron","year":"2010","journal-title":"Eur Heart J"},{"key":"2024041706385159500_suae002-B4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC working group on myocardial and pericardial diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"2024041706385159500_suae002-B5","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"2024041706385159500_suae002-B6","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"2024041706385159500_suae002-B7","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2024041706385159500_suae002-B8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/eurheartj\/ehab895","article-title":"Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics","volume":"43","author":"Arbustini","year":"2022","journal-title":"Eur Heart J"},{"key":"2024041706385159500_suae002-B9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000531534","article-title":"Comparison of clinical course and outcomes between dilated and hypokinetic non-dilated cardiomyopathy","volume":"148","author":"Dziewi\u0119cka","year":"2023","journal-title":"Cardiology"},{"key":"2024041706385159500_suae002-B10","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1093\/eurheartj\/ehac264","article-title":"Interpretation of genetic variants depends on a clinically guided integration of phenotype and molecular data","volume":"43","author":"Arbustini","year":"2022","journal-title":"Eur Heart J"},{"key":"2024041706385159500_suae002-B11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2014.05.027","article-title":"The MOGE(S) classification of cardiomyopathy for clinicians","volume":"64","author":"Arbustini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2024041706385159500_suae002-B12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jacc.2022.04.067","article-title":"Impediments to heart transplantation in adults with MELASMT-TL1:m.3243A&gt;G cardiomyopathy","volume":"80","author":"Di Toro","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024041706385159500_suae002-B13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2021.06.039","article-title":"Oxalic cardiomyopathy: could it influence treatment plans in patients with primary hyperoxaluria type 1?","volume":"78","author":"Di Toro","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2024041706385159500_suae002-B14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejheart.2005.11.003","article-title":"Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects","volume":"8","author":"Arbustini","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"2024041706385159500_suae002-B15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-0609.1989.tb01229.x","article-title":"Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients","volume":"42","author":"Barosi","year":"1989","journal-title":"Eur J Haematol"},{"key":"2024041706385159500_suae002-B16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2369-3-8","article-title":"Nephropathic cystinosis associated with cardiomyopathy: a 27-year clinical follow-up","volume":"3","author":"Dixit","year":"2002","journal-title":"BMC Nephrol"},{"key":"2024041706385159500_suae002-B17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jacc.2016.05.090","article-title":"Genetic screening of anderson-fabry disease in probands referred from multispecialty clinics","volume":"68","author":"Favalli","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2024041706385159500_suae002-B18","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jacc.2011.01.072","article-title":"Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects","volume":"58","author":"Diegoli","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2024041706385159500_suae002-B19","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2018.08.2182","article-title":"Cardiac phenotypes in hereditary muscle disorders: JACC state-of-the-art review","volume":"72","author":"Arbustini","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024041706385159500_suae002-B20","first-page":"512","article-title":"Diagnosis of cardiac amyloidosis made by ultrastructural examination of endomyocardial biopsy. A case report","volume":"14","author":"Arbustini","year":"1984","journal-title":"G Ital Cardiol"},{"key":"2024041706385159500_suae002-B21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0002-8703(95)90362-3","article-title":"Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients","volume":"130","author":"Arbustini","year":"1995","journal-title":"Am Heart J"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/26\/Supplement_1\/i1\/57239811\/suae002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/26\/Supplement_1\/i1\/57239811\/suae002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:29:37Z","timestamp":1713353377000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/26\/Supplement_1\/i1\/7646236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":21,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2024,4,17]]},"published-print":{"date-parts":[[2024,4,17]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suae002","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,4]]}}}